K. Pettersson

P. Laippala, S. Kivelä, H. Luukinen, 2000, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Europium Nanoparticle-Based High Performing Immunoassay for the Screening of Treponemal Antibodies

K. Pettersson, Sushil Kumar, N. Khanna, 2013, PloS one.

Simultaneous detection of Human Immunodeficiency Virus 1 and Hepatitis B virus infections using a dual-label time-resolved fluorometric assay

T. Soukka, K. Pettersson, R. Vainionpää, 2010, Journal of nanobiotechnology.

Intact and internally cleaved free prostate-specific antigen in patients with prostate cancer with different pathologic stages and grades.

K. Pettersson, M. Nurmi, K. Alanen, 2011, Urology.

Association of free‐prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue

M. Kattan, A. Haese*, H. Lilja, 2005, The Prostate.

Discrimination of prostate cancer from benign disease by plasma measurement of intact, free prostate-specific antigen lacking an internal cleavage site at Lys145-Lys146.

J. Hugosson, H. Lilja, T. Piironen, 2001, Clinical chemistry.

Identification and analysis of anti-HDL scFv-antibodies obtained from phage display based synthetic antibody library.

M. Jauhiainen, J. Metso, Priyanka Negi, 2016, Clinical biochemistry.

Rapid exponential elimination of free prostate-specific antigen contrasts the slow, capacity-limited elimination of PSA complexed to alpha 1-antichymotrypsin from serum.

H. Lilja, T. Piironen, K. Pettersson, 1998, Urology.

Three two-site apoA-I immunoassays using phage expressed detector antibodies - Preliminary clinical evaluation with cardiac patients.

J. Sinisalo, M. Jauhiainen, J. Metso, 2020, Journal of pharmaceutical and biomedical analysis.

Prostate Cancer Risk Stratification in Men With a Clinical Suspicion of Prostate Cancer Using a Unique Biparametric MRI and Expression of 11 Genes in Apparently Benign Tissue: Evaluation Using Machine‐Learning Techniques

H. Merisaari, P. Taimen, P. Boström, 2020, Journal of magnetic resonance imaging : JMRI.

Improving the Specificity of Screening for Lethal Prostate Cancer Using Prostate-specific Antigen and a Panel of Kallikrein Markers: A Nested Case-Control Study.

P. Scardino, P. Stattin, A. Vickers, 2015, European urology.

HE4 in the evaluation of tumor load and prognostic stratification of high grade serous ovarian carcinoma

S. Grénman, S. Hietanen, O. Carpén, 2020, Acta oncologica.

Comparison of predictive accuracy for pathologically organ confined clinical stage T1c prostate cancer using human glandular kallikrein 2 and prostate specific antigen combined with clinical stage and Gleason grade.

M. Kattan, D. Chan, A. Haese*, 2005, The Journal of urology.

Evaluation of a new immunoassay for cystatin C, based on a double monoclonal principle, in men with normal and impaired renal function

H. Lilja, A. Christensson, C. Savage, 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Cystatin C as a predictor of all-cause mortality and myocardial infarction in patients with non-ST-elevation acute coronary syndrome.

A. Christensson, P. Porela, K. Pulkki, 2012, Clinical biochemistry.

Early markers of myocardial injury: cTnI is enough.

P. Porela, L. Voipio‐Pulkki, K. Pulkki, 2009, Clinica chimica acta; international journal of clinical chemistry.

Free and total human glandular kallikrein 2 in patients with prostate cancer.

K. Pettersson, M. Nurmi, K. Alanen, 2006, Urology.

Novel sensitive cardiac troponin I immunoassay free from troponin I-specific autoantibody interference

B. Lindahl, P. Venge, K. Pettersson, 2014, Clinical chemistry and laboratory medicine.

Chimeric recombinant antibody fragments in cardiac troponin I immunoassay.

K. Pettersson, T. Lövgren, E. Brockmann, 2015, Clinical biochemistry.

Individual differences in lutropin immunoreactivity revealed by monoclonal antibodies.

K. Pettersson, J. Söderholm, 1991, Clinical chemistry.

Monoclonal antibody-based discrepancies between two-site immunometric tests for lutropin.

I. Huhtaniemi, K. Pettersson, Y. Ding, 1991, Clinical chemistry.

Prostate cancer risk SNP rs10993994 is a trans-eQTL for SNHG11 mediated through MSMB.

R. Klein, H. Lilja, P. Taimen, 2020, Human molecular genetics.

Immunoassay for the discrimination of free prostate-specific antigen (fPSA) forms with internal cleavages at Lys 145 or Lys 146 from fPSA without internal cleavages at Lys 145 or Lys 146

K. Pettersson, M. Nurmi, K. Alanen, 2014 .

Immuno‐based detection of extracellular vesicles in urine as diagnostic marker for prostate cancer

G. Jenster, K. Pettersson, C. Bangma, 2015, International journal of cancer.

Preclinical imaging of kallikrein-related peptidase 2 (hK2) in prostate cancer with a 111In-radiolabelled monoclonal antibody, 11B6

H. Lilja, S. Strand, A. Bjartell, 2014, EJNMMI Research.

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands

P. Scardino, A. Vickers, M. Roobol, 2010, British Journal of Cancer.

Urinary osteocalcin as a marker of bone metabolism.

P. Gerdhem, S. Käkönen, K. Pettersson, 2005, Clinical chemistry.

Associations Between Homocysteine, Bone Turnover, BMD, Mortality, and Fracture Risk in Elderly Women

P. Gerdhem, K. Pettersson, A. Isaksson, 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Biochemical markers of bone turnover are influenced by recently sustained fracture.

P. Gerdhem, K. Pettersson, K. Obrant, 2005, Bone.

A Nanoparticle-Based Approach for the Detection of Extracellular Vesicles

Laura Lehtinen, K. Pettersson, S. Wittfooth, 2019, Scientific Reports.

Effect of desialylation of highly purified isoforms of human luteinizing hormone on their bioactivity in vitro, radioreceptor activity and immunoactivity.

K. Pettersson, P. Burgon, D. Robertson, 1997, Reproduction, fertility, and development.

Serum estradiol, testosterone, and sex hormone-binding globulin as regulators of peak bone mass and bone turnover rate in young Finnish men.

U. Stenman, M. Välimäki, H. Alfthan, 2004, The Journal of clinical endocrinology and metabolism.

In vitro stability of free prostate-specific antigen (PSA) and prostate-specific antigen (PSA) complexed to alpha 1-antichymotrypsin in blood samples.

J. Oesterling, H. Lilja, U. Stenman, 1996, Urology.

Nanoparticle-Aided Detection of Colorectal Cancer-Associated Glycoconjugates of Extracellular Vesicles in Human Serum

K. Pettersson, K. Gidwani, R. Mahran, 2021, International journal of molecular sciences.

Free, complexed, and total serum prostate-specific antigen concentrations and their proportions in predicting stage, grade, and deoxyribonucleic acid ploidy in patients with adenocarcinoma of the prostate.

J. Oesterling, H. Lilja, H. Zincke, 1996, Urology.

Cardiac decompensation during an ischemic event weakens the predictive power of myocardial injury markers.

H. Helenius, P. Porela, L. Voipio‐Pulkki, 2000, Clinica chimica acta; international journal of clinical chemistry.

Development of troponin autoantibodies in experimental coxsackievirus B3 myocarditis

V. Kytö, A. Saraste, K. Pettersson, 2009, European journal of clinical investigation.

Comparison of cardiac troponin I immunoassays variably affected by circulating autoantibodies.

P. Porela, L. Voipio‐Pulkki, K. Pulkki, 2005, Clinical chemistry.

Beliefs in cardiac troponin testing.

K. Pettersson, S. Eriksson, 2005, Clinical chemistry.

Multi-Assay Point-of-Care Platform: Highly Sensitive Time-Resolved Fluorometric Detection in Combination with a Universal “All-In-One” Assay Format

K. Pettersson, S. Eriksson, H. Takalo, 2003 .

Antiantibodies to Cardiac Troponin Associate with Higher Initial Concentrations and Longer Release of Troponin I in Acute Coronary Syndrome Patients

M. Nieminen, J. Sinisalo, K. Pettersson, 2009 .

Binding of tyrosine-A-14(125I)-monoiodoinsulin to human erythrocytes.

T. Koivula, K. Pettersson, E. Kokko, 1984, Scandinavian journal of clinical and laboratory investigation.

Development of an immunoassay for the detection of cystatin C dimers.

L. Airas, K. Pettersson, J. Hellman, 2010, Journal of immunological methods.

A comparison of the free fraction of serum prostate specific antigen in men with benign and cancerous prostates: the best case scenario.

T. Stamey, H. Lilja, R. Wolfert, 1996, The Journal of urology.

Imaging androgen receptor signaling with a radiotracer targeting free prostate-specific antigen.

S. Larson, P. Scardino, Jason S. Lewis, 2012, Cancer discovery.

Sensitive and specific enzymatic assay for the determination of precursor forms of prostate-specific antigen after an activation step.

H. Lilja, M. Karp, K. Pettersson, 2002, Clinical chemistry.

Intact Free Prostate-Specific Antigen and Free and Total Human Glandular Kallikrein 2. Elimination of Assay Interference by Enzymatic Digestion of Antibodies to F(ab')(2) Fragments.

H. Lilja, K. Pettersson, M. Nurmi, 2006 .

Measurement of circulating forms of prostate-specific antigen in whole blood immediately after venipuncture: implications for point-of-care testing.

H. Lilja, T. Piironen, K. Irjala, 2001, Clinical chemistry.

Testing in serum for human glandular kallikrein 2, and free and total prostate specific antigen in biannual screening for prostate cancer.

J. Hugosson, H. Lilja, T. Piironen, 2003, The Journal of urology.

Phage display aided improvement of a unique prostate-specific antigen (PSA) antibody unreactive with Lys(145)-Lys(146) internally cleaved forms.

K. Pettersson, M. Vehniäinen, E. Brockmann, 2015, Journal of immunological methods.

Immunological characterization of human luteinizing hormone with special regard to a common genetic variant.

K. Pettersson, M. Seppälä, C. Nilsson, 2001, The Journal of endocrinology.

Production and characterization of novel anti-prostate-specific antigen (PSA) monoclonal antibodies that do not detect internally cleaved Lys145-Lys146 inactive PSA.

H. Lilja, T. Piironen, K. Pettersson, 2000, Clinical Chemistry.

Production and Characterization of Novel Anti-Prostate-specific Antigen ( PSA ) Monoclonal Antibodies That Do Not Detect Internally Cleaved Lys 145-Lys 146 Inactive PSA

H. Lilja, T. Piironen, K. Pettersson, 2000 .

Sensitive and specific immunodetection of human glandular kallikrein 2 in serum.

H. Lilja, T. Piironen, K. Pettersson, 2000, Clinical chemistry.

Characterization of Serum Tartrate‐Resistant Acid Phosphatase and Development of a Direct Two‐Site Immunoassay

M. Karp, S. Käkönen, K. Pettersson, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A Dual‐Label Immunofluorometric Assay for Human Osteocalcin

M. Karp, S. Käkönen, K. Pettersson, 1998, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Immunoreactivity of recombinant human glandular kallikrein using monoclonal antibodies raised against prostate‐specific antigen

H. Lilja, M. Karp, T. Piironen, 1997, The Prostate.

Epitope mapping of human prostate specific antigen and glandular kallikrein expressed in insect cells

M. Karp, T. Piironen, K. Pettersson, 1997, Prostate Cancer and Prostatic Diseases.

Epitope mapping of nine monoclonal antibodies against osteocalcin: Combinations into two‐site assays affect both assay specificity and sample stability

M. Karp, S. Käkönen, K. Pettersson, 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Ultrasensitive two-site immunometric assay of human lutropin by time-resolved fluorometry.

K. Pettersson, J. Söderholm, 1990, Clinical chemistry.

Evaluation of a New Skeletal Troponin I Assay in Patients with Idiopathic Inflammatory Myopathies.

K. Pettersson, I. Lundberg, L. Pirilä, 2020, The journal of applied laboratory medicine.

Novel homogenous time-resolved fluorometric RT-PCR assays for quantification of PSA and hK2 mRNAs in blood.

H. Lilja, K. Pettersson, P. Helo, 2007, Clinical biochemistry.

Dual-label time-resolved immunofluorometric assay for simultaneous determination of pregnancy-associated plasma protein A and free beta-subunit of human chorionic gonadotrophin.

B. No̸rgaard-Pedersen, M. Christiansen, K. Pettersson, 1997, Journal of immunological methods.

Development of highly fluorescent detection reagents for the construction of ultrasensitive immunoassays.

K. Pettersson, T. Lövgren, Q. Qin, 2001, Analytical chemistry.

Monoclonal antibody-based dual-label time-resolved fluorometric assays in a simplified one-step format.

K. Pettersson, T. Lövgren, L. Meriö, 1996, Clinical chemistry.

Simultaneous assay of alpha-fetoprotein and free beta subunit of human chorionic gonadotropin by dual-label time-resolved immunofluorometric assay.

B. No̸rgaard-Pedersen, S. Larsen, U. Stenman, 1993, Clinical chemistry.

Influence of coupling method on the luminescence properties, coupling efficiency, and binding affinity of antibodies labeled with europium (III) chelates.

K. Pettersson, T. Lövgren, A. Toivonen, 1997, Bioconjugate chemistry.

Time-resolved Fluorescence in Immunocytochemical Detection of Prostate-specific Antigen in Prostatic Tissue Sections

H. Lilja, A. Bjartell, K. Pettersson, 2004, The Histochemical Journal.

CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242.

C. Haglund, C. Böckelman, T. Kaprio, 2021, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

Determination of hormones by time-resolved fluoroimmunoassay.

E. Bertoft, K. Pettersson, T. Lövgren, 1984, Talanta.

An immunologically anomalous luteinizing hormone variant in a healthy woman.

I. Huhtaniemi, K. Pettersson, Y. Ding, 1992, The Journal of clinical endocrinology and metabolism.

The role of luteinizing hormone-beta gene polymorphism in the onset and progression of puberty in healthy boys.

T. Raivio, L. Dunkel, M. Siimes, 1996, The Journal of clinical endocrinology and metabolism.

Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein (hK2) in serum.

H. Lilja, M. Karp, T. Piironen, 1996, Clinical chemistry.

Diagnostic potential of nanoparticle aided assays for MUC16 and MUC1 glycovariants in ovarian cancer

Shruti Jain, K. Pettersson, K. Sundfeldt, 2022, International journal of cancer.

A two-site delfia immunoassay for measurements of the N-terminal peptide of pro-atrial natriuretic peptide (nANP).

M. Stridsberg, K. Pettersson, T. Pettersson, 1997, Upsala journal of medical sciences.

Lanthanide chelate complementation and hydrolysis enhanced luminescent chelate in real-time reverse transcription polymerase chain reaction assays for KLK3 transcripts.

P. Taimen, T. Soukka, K. Pettersson, 2014, Analytical biochemistry.

Epitope specificity and IgG subclass distribution of autoantibodies to cardiac troponin.

J. Sinisalo, K. Pettersson, S. Wittfooth, 2013, Clinical chemistry.

Autoantibodies to cardiac troponin associate with higher initial concentrations and longer release of troponin I in acute coronary syndrome patients.

M. Nieminen, J. Sinisalo, K. Pettersson, 2009, Clinical chemistry.

Sensitive and quantitative, 10-min immunofluorometric assay for D-Dimer in whole blood.

K. Punnonen, K. Pettersson, V. Harjola, 2006, Thrombosis research.

Enzymes and Pro * 1 n-- Immunofluorometric assay for sensitive and specific measurement of human prostatic glandular kallikrein ( hK 2 ) in serum

M. Karp, K. Pettersson, Å. Lundwall, 2004 .

Time-resolved fluorescence imaging for specific and quantitative immunodetection of human kallikrein 2 and prostate-specific antigen in prostatic tissue sections.

H. Lilja, A. Bjartell, T. Piironen, 2000, Urology.

A Rapid And Sensitive Immunoassay For Determination Of S-100 Protein In A Point-Of-Care Setting

K. Pettersson, S. Eriksson, L. Dean, 2004 .

The Proportion of Carboxylated to Total or Intact Osteocalcin in Serum Discriminates Warfarin‐Treated Patients from Control Subjects

J. Astermark, S. Käkönen, K. Pettersson, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Identification of novel proteolytic forms of osteocalcin in human urine.

P. Gerdhem, S. Käkönen, K. Pettersson, 2003, Biochemical and biophysical research communications.

Two‐Site Immunoassays for Osteoclastic Tartrate‐Resistant Acid Phosphatase Based on Characterization of Six Monoclonal Antibodies

M. Karp, Pirjo Laaksonen, S. Käkönen, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Autoantibody prevalence with an improved immunoassay for detecting cardiac troponin-specific autoantibodies

P. Porela, K. Pettersson, S. Wittfooth, 2014, Clinical chemistry and laboratory medicine.

Integrins are enriched on aberrantly fucosylated tumour‐derived urinary extracellular vesicles

G. Jenster, P. Boström, A. Hendrix, 2022, Journal of Extracellular Biology.

Elevation of cardiac troponins measured after recreational resistance training.

B. Lindahl, P. Venge, K. Pettersson, 2015, Clinical biochemistry.

Intact free prostate-specific antigen and free and total human glandular kallikrein 2. Elimination of assay interference by enzymatic digestion of antibodies to F(ab')2 fragments.

H. Lilja, K. Pettersson, M. Nurmi, 2006, Analytical chemistry.

Time-resolved fluorescence imaging (TRFI) for direct immunofluorescence of PSA and alpha-1-antichymotrypsin in prostatic tissue sections

H. Lilja, A. Bjartell, K. Pettersson, 1999, Prostate Cancer and Prostatic Diseases.

Demonstration of the Predominant Urine Osteocalcin Fragments Detectable by Two‐Site Immunoassays

M. Karp, S. Käkönen, K. Pettersson, 1999, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

LH Measurements by in Vitro Bioassay and a Highly Sensitive Immunofluorometric Assay Improve the Distinction between Boys with Constitutional Delay of Puberty and Hypogonadotropic Hypogonadism

L. Dunkel, I. Huhtaniemi, A. Haavisto, 1990, Pediatric Research.

Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein A: use in first-trimester screening for Down syndrome.

M. Christiansen, K. Pettersson, Q. Qin, 2002, Clinical chemistry.

Autoantibodies to cardiac troponin in acute coronary syndromes.

B. Lindahl, P. Venge, R. Gedeborg, 2010, Clinica chimica acta; international journal of clinical chemistry.

Simultaneous quantification of prostate-specific antigen and human glandular kallikrein 2 mRNA in blood samples from patients with prostate cancer and benign disease.

H. Lilja, M. Karp, K. Irjala, 2002, Clinical chemistry.

Time-resolved fluorescence based direct two-site apoA-I immunoassays and their clinical application in patients with suspected obstructive coronary artery disease

J. Knuuti, M. Jauhiainen, J. Metso, 2022, Frontiers in Cardiovascular Medicine.

SimultaneousQuadruple-LabelFluorometricImmunoassayof Thyroid-Stimulating Hormone, 17a-Hydroxyprogesterone,ImmunoreactiveTrypsin, and Creatine Kinase MM Isoenzymein Dried Blood Spots

K. Pettersson, T. Lövgren, H. Mikola, 1992 .

Luteinizing hormone, its beta-subunit variant, and epithelial ovarian cancer: the gonadotropin hypothesis revisited.

A. Zeleniuch‐Jacquotte, I. Huhtaniemi, K. Pettersson, 2001, American journal of epidemiology.

Genetic variant of luteinizing hormone and risk of breast cancer in older women.

A. Zeleniuch‐Jacquotte, I. Huhtaniemi, K. Pettersson, 2000, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Characterization and processing of prostate specific antigen (hK3) and human glandular kallikrein (hK2) secreted by LNCaP cells

H. Lilja, T. Piironen, K. Pettersson, 1999, Prostate Cancer and Prostatic Diseases.

Introduction of lysine residues on the light chain constant domain improves the labelling properties of a recombinant Fab fragment.

T. Teeri, K. Takkinen, A. Hemminki, 1995, Protein engineering.

Elevated Serum Free Pregnancy-Associated Plasma Protein-A Independently Predicts Mortality in Haemodialysis Patients but Is Not Associated with Recurrent Haemodialysis-Induced Ischaemic Myocardial Injury

K. Pettersson, C. McIntyre, Helen J. Jefferies, 2015, Nephron.

Intravenous administration of low molecular weight and unfractionated heparin elicits a rapid increase in serum pregnancy-associated plasma protein A.

P. Porela, K. Pettersson, S. Wittfooth, 2009, Clinical chemistry.

Fracture-induced changes in bone turnover: a potential confounder in the use of biochemical markers in osteoporosis

S. Käkönen, K. Pettersson, P. Josefsson, 2004, Journal of Bone and Mineral Metabolism.

Dry-reagent double-monoclonal assay for cystatin C.

K. Pettersson, A. Grubb, Noora Ristiniemi, 2010, Clinical chemistry.

Significance and metabolism of complexed and noncomplexed prostate specific antigen forms, and human glandular kallikrein 2 in clinically localized prostate cancer before and after radical prostatectomy.

A. Haese*, H. Lilja, H. Huland, 1999, The Journal of urology.

Comparability of the Tandem-R and IMx assays for the measurement of serum prostate-specific antigen.

J. Oesterling, H. Lilja, K. Pettersson, 1994, Urology.

One-step all-in-one dry reagent immunoassays with fluorescent europium chelate label and time-resolved fluorometry.

K. Pettersson, T. Lövgren, T Lövgren, 1996, Clinical chemistry.

Release of Intact and Fragmented Osteocalcin Molecules from Bone Matrix during Bone Resorption in Vitro*

K. Pettersson, T. Hentunen, H. Väänänen, 2004, Journal of Biological Chemistry.

Synthesis, purification and structural and functional characterization of recombinant form of a common genetic variant of human luteinizing hormone.

I. Huhtaniemi, P. Manna, V. Reinhold, 2002, Human Molecular Genetics.

Time-resolved fluoroimmunoassay of human choriogonadotropin.

U. Stenman, K. Pettersson, T. Lövgren, 1983, Clinical chemistry.

Patterns of LHβcf among women in health and disease

J. Gaughan, K. Pettersson, S. Birken, 2007, Molecular and Cellular Endocrinology.

Prevalence of an immunological LH β‐subunit variant in a UK population of healthy women and women with polycystic ovary syndrome

P. Jones, I. Huhtaniemi, R. Clayton, 1995, Clinical endocrinology.

Occurrence and biological properties of a common genetic variant of luteinizing hormone.

I. Huhtaniemi, A. Haavisto, K. Pettersson, 1995, The Journal of clinical endocrinology and metabolism.

Concanavalin A affinity chromatography of human serum gonadotropins: evidence for changes of carbohydrate structure in different clinical conditions.

K. Pettersson, C. Ronin, P. Beck-Peccoz, 1993, The Journal of clinical endocrinology and metabolism.

Sensitive LH and FSH assays for monitoring low serum levels in men undergoing steroidal contraception

K. Pettersson, D. Robertson, E. Pruysers, 2001, Clinical endocrinology.

Quantitative, wide-range, 5-minute point-of-care immunoassay for total human chorionic gonadotropin in whole blood.

Kim Pettersson, K. Pettersson, Piia von Lode, 2004, Clinical chemistry.

Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down syndrome.

B. No̸rgaard-Pedersen, M. Christiansen, M. Christiansen, 1997, Clinical chemistry.

Serum levels of beta-subunit of chorionic gonadotropin in patients with pituitary tumors.

P. Beck‐Peccoz, K. Pettersson, A. Spada, 1995, European journal of endocrinology.

Abnormal response of luteinizing hormone beta subunit to thyrotrophin‐releasing hormone in patients with non‐functioning pituitary adenoma

K. Pettersson, G. Faglia, A. Spada, 1994, Clinical endocrinology.

A new contributing factor to polycystic ovary syndrome: the genetic variant of luteinizing hormone.

I. Huhtaniemi, R. Clayton, B. Fauser, 1999, The Journal of clinical endocrinology and metabolism.

Worldwide frequency of a common genetic variant of luteinizing hormone: an international collaborative research. International Collaborative Research Group.

M. Matzuk, I. Huhtaniemi, K. Pettersson, 1997, Fertility and sterility.

The Polymorphisms of Gonadotropin Action: Molecular Basis and Clinical Implications

K. Aittomäki, I. Huhtaniemi, P. Pakarinen, 1996 .

Monitoring the LH Surge by Ultrarapid and Highly Sensitive Immunofluorometric Assay

U. Stenman, H. Alfthan, K. Pettersson, 1985, Annals of the New York Academy of Sciences.

Disparate response of wild-type and variant forms of LH to GnRH stimulation in individuals heterozygous for the LHbeta variant allele.

I. Huhtaniemi, M. Kaleva, A. Haavisto, 2001, Human reproduction.

Mutations and polymorphisms in gonadotropin genes

I. Huhtaniemi, K. Pettersson, C. Nilsson, 1999, Molecular and Cellular Endocrinology.

A common polymorphic allele of the human luteinizing hormone beta-subunit gene: additional mutations and differential function of the promoter sequence.

I. Huhtaniemi, P. Pakarinen, K. Pettersson, 1999, Human molecular genetics.

Alterations in gonadal steroidogenesis in individuals expressing a common genetic variant of luteinizing hormone

I. Huhtaniemi, K. Pettersson, 1999, The Journal of Steroid Biochemistry and Molecular Biology.

Determination of a common genetic variant of luteinizing hormone using DNA hybridization and immunoassays

S. Easteal, I. Huhtaniemi, K. Pettersson, 1998, Clinical endocrinology.

Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism.

P. Humaidan, K. Pettersson, R. Clarizia, 2011, Reproductive biomedicine online.

The frequency of an inactivating point mutation (566C-->T) of the human follicle-stimulating hormone receptor gene in four populations using allele-specific hybridization and time-resolved fluorometry.

A. de la Chapelle, K. Aittomäki, I. Huhtaniemi, 1998, The Journal of clinical endocrinology and metabolism.

Role of lectin microarrays in cancer diagnosis

Kim Pettersson, K. Pettersson, U. Lamminmäki, 2016, Proteomics.

Time-resolved fluorescence resonance energy transfer assay for point-of-care testing of urinary albumin.

Kim Pettersson, Olli Peltola, K. Pettersson, 2003, Clinical chemistry.

Comparison of immunoassay technologies.

K. Pettersson, 1993, Clinical chemistry.

Development of anti-immunocomplex specific antibodies and non-competitive time-resolved fluorescence immunoassay for the detection of estradiol

K. Pettersson, U. Lamminmäki, Etvi Juntunen, 2019, Analytical and Bioanalytical Chemistry.

Sensitive protein detection via triple-binder proximity ligation assays

Ulf Landegren, Kim Pettersson, U. Landegren, 2007, Nature Methods.

Sensitive bioaffinity assays with individual microparticles and time-resolved fluorometry.

K. Pettersson, T. Lövgren, H. Hakala, 1997, Clinical chemistry.

Present and Future Biochemical Markers for Detection of Acute Coronary Syndrome

K. Pettersson, S. Wittfooth, S. Eriksson, 2006, Critical reviews in clinical laboratory sciences.

Altered PCA3 and TMPRSS2-ERG expression in histologically benign regions of cancerous prostates: a systematic, quantitative mRNA analysis in five prostates

P. Taimen, P. Boström, K. Pettersson, 2015, BMC Urology.

Cancer-associated changes in the expression of TMPRSS2-ERG, PCA3, and SPINK1 in histologically benign tissue from cancerous vs noncancerous prostatectomy specimens.

Andrew J Vickers, Kim Pettersson, Angel M Cronin, 2014, Urology.

A longitudinal analysis of CA125 glycoforms in the monitoring and follow up of high grade serous ovarian cancer.

Shruti Jain, S. Grénman, S. Hietanen, 2019, Gynecologic oncology.

A randomized trial of early detection of clinically significant prostate cancer (ProScreen): study design and rationale

T. Lehtimäki, T. Tammela, A. Auvinen, 2017, European Journal of Epidemiology.

Evaluation of molecular forms of prostate‐specific antigen and human kallikrein 2 in predicting biochemical failure after radical prostatectomy

B. Guillonneau, P. Scardino, J. Eastham, 2009, International journal of cancer.

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.

Hartwig Huland, Ville Vaisanen, Andrew J Vickers, 2007, Clinical chemistry.

Risk assessment for biochemical recurrence prior to radical prostatectomy: Significant enhancement contributed by human glandular kallikrein 2 (hK2) and free prostate specific antigen (PSA) in men with moderate PSA‐elevation in serum

Hartwig Huland, Andrew J Vickers, Kim Pettersson, 2006, International journal of cancer.

Degradation of cardiac troponin I: implication for reliable immunodetection.

L. Voipio‐Pulkki, K. Pulkki, A. Bereznikova, 1998, Clinical chemistry.

Simultaneous quantification of human glandular kallikrein 2 and prostate-specific antigen mRNAs in peripheral blood from prostate cancer patients.

H. Lilja, M. Karp, K. Pettersson, 2001, The Journal of molecular diagnostics : JMD.

Free vs total pregnancy-associated plasma protein A (PAPP-A) as a predictor of 1-year outcome in patients presenting with non-ST-elevation acute coronary syndrome.

P. Porela, L. Voipio‐Pulkki, K. Pulkki, 2010, Clinical chemistry.

Association of transcript levels of 10 established or candidate-biomarker gene targets with cancerous versus non-cancerous prostate tissue from radical prostatectomy specimens.

H. Lilja, K. Pettersson, Leni Kauko, 2013, Clinical biochemistry.

Circulating prostate tumor cells detected by reverse transcription-PCR in men with localized or castration-refractory prostate cancer: concordance with CellSearch assay and association with bone metastases and with survival.

Hartwig Huland, Kim Pettersson, Angel M Cronin, 2009, Clinical chemistry.

Innovations in serum and urine markers in prostate cancer current European research in the P-Mark project.

T M Luider, F. Hamdy, O. Nilsson, 2005, European urology.

Global expression of AMACR transcripts predicts risk for prostate cancer – a systematic comparison of AMACR protein and mRNA expression in cancerous and noncancerous prostate

Pekka Taimen, Kim Pettersson, Peter J Boström, 2016, BMC Urology.

Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate‐specific antigen

P. Scardino, A. Vickers, J. Hugosson, 2010, Cancer.

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

Andrew J Vickers, Kim Pettersson, Angel M Cronin, 2008, BMC medicine.

Development of sensitive immunoassays for free and total human glandular kallikrein 2.

Kim Pettersson, Hans Lilja, Ville Väisänen, 2004, Clinical chemistry.

Levels of beta-microseminoprotein in blood and risk of prostate cancer in multiple populations.

B. Henderson, C. Haiman, L. Kolonel, 2013, Journal of the National Cancer Institute.

Quantitative Time-Resolved Fluorescence Imaging of Androgen Receptor and Prostate-Specific Antigen in Prostate Tissue Sections

H. Lilja, A. Bjartell, K. Pettersson, 2016, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication.

Kim Pettersson, Fritz Schröder, Hans Lilja, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A common polymorphic allele of the LH beta-subunit gene is associated with higher exogenous FSH consumption during controlled ovarian stimulation for assisted reproductive technology

P. Humaidan, K. Pettersson, R. Clarizia, 2013, Reproductive Biology and Endocrinology.

Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum.

H. Lilja, T. Piironen, K. Pettersson, 1995, Clinical chemistry.

Prostate-specific antigen in serum occurs predominantly in complex with alpha 1-antichymotrypsin.

O. Nilsson, H. Lilja, A. Christensson, 1991, Clinical chemistry.

Lectin nanoparticle assays for detecting breast cancer-associated glycovariants of cancer antigen 15-3 (CA15-3) in human plasma

P. Kellokumpu-Lehtinen, K. Pettersson, U. Lamminmäki, 2019, PloS one.

Human glandular kallikrein 2 levels in serum for discrimination of pathologically organ‐confined from locally‐advanced prostate cancer in total PSA‐levels below 10 ng/ml

A. Haese*, H. Lilja, M. Graefen, 2001, The Prostate.

Enhanced Expression of Prostate-Specific Antigen in the Transition Zone of the Prostate

T. Piironen, K. Pettersson, M. Kwiatkowski, 1998, European Urology.

Primary breast cancer biomarkers based on glycosylation and extracellular vesicles detected from human serum

P. Härkönen, K. Pettersson, S. Wittfooth, 2021, Cancer reports.

Sensitive and quantitative detection of cardiac troponin I with upconverting nanoparticle lateral flow test with minimized interference

K. Pettersson, S. Wittfooth, P. Hedberg, 2021, Scientific Reports.

Escherichia coli–expressed near full length HIV-1 envelope glycoprotein is a highly sensitive and specific diagnostic antigen

T. Soukka, K. Pettersson, S. Swaminathan, 2012, BMC Infectious Diseases.

Time-resolved fluorometry (TRF)-based immunoassay concept for rapid and quantitative determination of biochemical myocardial infarction markers from whole blood, serum and plasma.

K Irjala, K. Irjala, K. Pettersson, 2000, Luminescence : the journal of biological and chemical luminescence.

FGF‐8b induces growth and rich vascularization in an orthotopic PC‐3 model of prostate cancer

P. Härkönen, K. Pettersson, H. Väänänen, 2009, Journal of cellular biochemistry.

Lateral flow immunoassay with upconverting nanoparticle‐based detection for indirect measurement of interferon response by the level of MxA

Tero Soukka, Kim Pettersson, Iida Martiskainen, 2017, Journal of medical virology.

Effects of blood sample anticoagulants on lateral flow assays using luminescent photon-upconverting and Eu(III) nanoparticle reporters.

R. Arppe, T. Soukka, K. Pettersson, 2016, Analytical biochemistry.

Detection of Bladder Cancer with Aberrantly Fucosylated ITGA3.

K. Pettersson, U. Lamminmäki, K. Gidwani, 2021, Analytical biochemistry.

Europium Nanoparticle-Based Sialyl-Tn Monoclonal Antibody Discriminates Epithelial Ovarian Cancer-Associated CA125 from Benign Sources.

M. Poutanen, O. Carpén, K. Pettersson, 2019, The journal of applied laboratory medicine.

Rapid one-step immunofluorometric assay for measuring soluble transferrin receptor in whole blood.

K. Irjala, K. Pettersson, T. Takala, 2004, Clinical chemistry.

Prospective validation of microseminoprotein‐β added to the 4Kscore in predicting high‐grade prostate cancer in an international multicentre cohort

M. Cooperberg, A. Haese*, S. Boorjian, 2020, BJU international.

Pitfalls in the Dextran-coated charcoal assay of estrogen receptors in breast cancer tissue.

K. Pettersson, J. Söderholm, R. Vanharanta, 1985, Journal of steroid biochemistry.

Can one blood draw replace transrectal ultrasonography‐estimated prostate volume to predict prostate cancer risk?

P. Scardino, A. Vickers, D. Sjoberg, 2013, BJU international.

Free and complexed prostate-specific antigen (PSA): in vitro stability, epitope map, and development of immunofluorometric assays for specific and sensitive detection of free PSA and PSA-alpha 1-antichymotrypsin complex.

H. Lilja, A. Christensson, T. Piironen, 1995, Clinical chemistry.

Free, complexed and total serum prostate specific antigen: the establishment of appropriate reference ranges for their concentrations and ratios.

J. Oesterling, H. Lilja, U. Stenman, 1995, The Journal of urology.

Glycovariant-based lateral flow immunoassay to detect ovarian cancer–associated serum CA125

M. Poutanen, K. Pettersson, U. Lamminmäki, 2020, Communications Biology.

Biochemical Markers of Bone Metabolism and Prediction of Fracture in Elderly Women

Anders Isaksson, Kim Pettersson, P. Gerdhem, 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam

Andrew J Vickers, Kim Pettersson, Angel M Cronin, 2010, Clinical Cancer Research.

of Screening for Prostate Cancer , Rotterdam StudyRecent Screening : Data from the European Randomized A Four-Kallikrein Panel Predicts Prostate Cancer in Men with

P. Scardino, A. Vickers, M. Roobol, 2010 .

Clinical value of human glandular kallikrein 2 and free and total prostate-specific antigen in serum from a population of men with prostate-specific antigen levels 3.0 ng/mL or greater.

J. Hugosson, H. Lilja, T. Piironen, 2000, Urology.

Discrimination of men with prostate cancer from those with benign disease by measurements of human glandular kallikrein 2 (HK2) in serum.

J. Oesterling, H. Lilja, T. Piironen, 2000, The Journal of urology.

Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate Cancer

H. Merisaari, P. Taimen, P. Boström, 2021, Journal of magnetic resonance imaging : JMRI.

Comparison of analysis of the different prostate-specific antigen forms in serum for detection of clinically localized prostate cancer.

J. Oesterling, H. Lilja, U. Stenman, 1996, Urology.

Structural investigation of the alpha‐1‐antichymotrypsin: Prostate‐specific antigen complex by comparative model building

H. Lilja, B. Villoutreix, K. Pettersson, 1996, Protein science : a publication of the Protein Society.

Production of recombinant PSA and HK2 and analysis of their immunologic cross-reactivity.

H. Lilja, M. Karp, T. Piironen, 1995, Biochemical and biophysical research communications.

Free-to-total prostate-specific antigen (PSA) ratio improves the specificity for detecting prostate cancer in patients with prostatism and intermediate PSA levels.

T. Piironen, K. Pettersson, M. Kwiatkowski, 1998, British journal of urology.

Human glandular kallikrein as a tool to improve discrimination of poorly differentiated and non-organ-confined prostate cancer compared with prostate-specific antigen.

T. Piironen, K. Pettersson, M. Kwiatkowski, 2000, Urology.

A europium chelate for quantitative point-of-care immunoassays using direct surface measurement.

Kim Pettersson, Harri Takalo, K. Pettersson, 2003, Analytical chemistry.

Characterization of monoclonal antibodies against prostate specific antigen produced by genetic immunization.

H. Nevanlinna, U. Stenman, K. Pettersson, 2004, Journal of immunological methods.

Determination and analysis of antigenic epitopes of prostate specific antigen (PSA) and human glandular kallikrein 2 (hK2) using synthetic peptides and computer modeling

M. Vihinen, H. Lilja, B. Villoutreix, 1998, Protein science : a publication of the Protein Society.

Leakage of cardiac troponin I in aortic valve stenosis

J. Lommi, M. Kupari, K. Pettersson, 2005, Journal of internal medicine.

Level of circulating phospholipase A2 in prediction of the prognosis of patients with suspected myocardial infarction

P. Porela, L. Voipio‐Pulkki, K. Pulkki, 2000, Basic Research in Cardiology.

Prostate-Specific Antigen in Serum Occurs Predominantly in Complex with a . 1-Antichymotrypsin

K. Pettersson, Ulrika, Dahl, 2004 .

Prostate-Specificin SerumOccursPredominantly in Complexwith a.1-Antichymotrypsin

H. Lilja, K. Pettersson, Ulrika Dahl, 1991 .

Exploratory Analysis of CA125-MGL and -STn Glycoforms in the Differential Diagnostics of Pelvic Masses.

T. Laajala, M. Poutanen, S. Grénman, 2020, The journal of applied laboratory medicine.

Improved early risk stratification and diagnosis of myocardial infarction, using a novel troponin I assay concept

P. Porela, L. Voipio‐Pulkki, K. Pulkki, 2005, European journal of clinical investigation.

Immunoassay for the discrimination of free prostate-specific antigen (fPSA) forms with internal cleavages at Lys(₁₄₅) or Lys(₁₄₆) from fPSA without internal cleavages at Lys(₁₄₅) or Lys(₁₄₆).

H. Lilja, K. Pettersson, M. Nurmi, 2011, Journal of immunological methods.

New approach to standardisation of human cardiac troponin I (cTnI).

A. Katrukha, A. Bereznikova, K. Pettersson, 1999, Scandinavian journal of clinical and laboratory investigation. Supplementum.

Prediction of short-term outcome in patients with suspected myocardial infarction.

H. Helenius, P. Porela, L. Voipio‐Pulkki, 2000, Annals of emergency medicine.

Skeletal troponin I cross-reactivity in different cardiac troponin I assay versions.

Kim Pettersson, K. Pettersson, Heidi Hyytiä, 2015, Clinical biochemistry.

Troponin-specific autoantibody interference in different cardiac troponin I assay configurations.

Kim Pettersson, B. Lindahl, P. Venge, 2012, Clinical chemistry.

An interfering component in cardiac troponin I immunoassays-Its nature and inhibiting effect on the binding of antibodies against different epitopes.

Kim Pettersson, K. Pettersson, S. Eriksson, 2004, Clinical biochemistry.

Cardiac troponin elevations in marathon runners. Role of coronary atherosclerosis and skeletal muscle injury. The MaraCat Study.

J. Knuuti, A. Saraste, K. Pettersson, 2019, International journal of cardiology.

Clinical significance of troponin I efflux and troponin autoantibodies in patients with dilated cardiomyopathy.

E. Vanninen, J. Kuusisto, K. Peuhkurinen, 2008, Journal of Cardiac Failure.

Circulating Pregnancy-Associated Plasma Protein A Predicts Outcome in Patients With Acute Coronary Syndrome but No Troponin I Elevation

P. Porela, L. Voipio‐Pulkki, K. Pulkki, 2003, Circulation.

Potentially pathogenic circulating autoantibodies to cardiac troponin are present in hemodialysis patients

K. Pettersson, C. McIntyre, Helen J. Jefferies, 2017, Hemodialysis international. International Symposium on Home Hemodialysis.

Release Patterns of Pregnancy Associated Plasma Protein A (PAPP-A) in Patients with Acute Coronary Syndromes

K. Pettersson, S. Eriksson, P. Laitinen, 2002, Scandinavian cardiovascular journal : SCJ.

A new simple and rapid dual assay for AFP and free β hCG in screening for Down syndrome

R. Salonen, B. No̸rgaard-Pedersen, S. Larsen, 1994, Clinical genetics.

Cloning, sequencing, expression and characterization of three anti-estradiol-17beta Fab fragments.

M. Karp, K. Pettersson, P. Saviranta, 1997, Biochimica et biophysica acta.

Simultaneous quadruple-label fluorometric immunoassay of thyroid-stimulating hormone, 17 alpha-hydroxyprogesterone, immunoreactive trypsin, and creatine kinase MM isoenzyme in dried blood spots.

K. Pettersson, T. Lövgren, H. Mikola, 1992, Clinical chemistry.

Direct Immunoassay for Free Pregnancy-Associated Plasma Protein A (PAPP-A).

P. Porela, L. Voipio‐Pulkki, K. Pulkki, 2018, The journal of applied laboratory medicine.

A Panel of Kallikrein Marker Predicts Prostate Cancer in a Large, Population-Based Cohort Followed for 15 Years without Screening

Andrew J Vickers, Kim Pettersson, Anders Dahlin, 2010, Cancer Epidemiology, Biomarkers & Prevention.

In prostatism patients the ratio of human glandular kallikrein to free PSA improves the discrimination between prostate cancer and benign hyperplasia within the diagnostic "gray zone" of total PSA 4 to 10 ng/mL.

T. Piironen, K. Pettersson, M. Kwiatkowski, 1998, Urology.

Stratification of aggressive prostate cancer from indolent disease-Prospective controlled trial utilizing expression of 11 genes in apparently benign tissue.

Ivan Jambor, Matthias Nees, Pekka Taimen, 2016, Urologic oncology.

Improved surface stability and biotin binding properties of streptavidin coating on polystyrene.

Lasse Välimaa, Kim Pettersson, Harri Takalo, 2009, Colloids and surfaces. B, Biointerfaces.

Standardization of two immunoassays for human glandular kallikrein 2.

D. Chan, A. Haese*, A. Partin, 2003, Clinical chemistry.

Urinary osteocalcin is a useful marker for monitoring the effect of alendronate therapy.

P. Kannus, A. Heinonen, K. Pettersson, 2005, Clinical chemistry.

Development and evaluation of three immunofluorometric assays that measure different forms of osteocalcin in serum.

M. Karp, Pirjo Laaksonen, S. Käkönen, 2000, Clinical chemistry.

Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results.

T. Soukka, K. Pettersson, K. Sundfeldt, 2019, Molecular aspects of medicine.

A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel

S. Jalkanen, C. Haglund, C. Böckelman, 2021, Scientific Reports.

The importance of human glandular kallikrein and its correlation with different prostate specific antigen serum forms in the detection of prostate carcinoma

K. Pettersson, M. Kwiatkowski, F. Recker, 1998, Cancer.

Double-Antigen Lateral Flow Immunoassay for the Detection of Anti-HIV-1 and -2 Antibodies Using Upconverting Nanoparticle Reporters

Gaurav Batra, Kim Pettersson, Navin C. Khanna, 2021, Sensors.

Upconverting nanoparticle reporter–based highly sensitive rapid lateral flow immunoassay for hepatitis B virus surface antigen

K. Pettersson, Dinesh Kumar, N. Khanna, 2020, Analytical and Bioanalytical Chemistry.

Measurement and clinical significance of circulating PAPP-A in ACS patients.

K. Pettersson, S. Wittfooth, Q. Qin, 2007, Clinica chimica acta; international journal of clinical chemistry.

A Nanoparticle-Based Approach for the Detection of Extracellular Vesicles

Laura Lehtinen, K. Pettersson, S. Wittfooth, 2019, Scientific reports.

A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources.

M. Poutanen, S. Grénman, O. Carpén, 2016, Clinical chemistry.

Quantitative real-time RT-PCR assay for PCA3.

K. Pettersson, S. Junnila, M. Nurmi, 2008, Clinical biochemistry.

Combined inhibin and CA125 assays in the detection of ovarian cancer.

H. Burger, M. McGuckin, K. Pettersson, 1999, Clinical chemistry.

Discrimination of benign from malignant prostatic disease by selective measurements of single chain, intact free prostate specific antigen.

A. Haese*, H. Lilja, M. Graefen, 2002, The Journal of urology.

Simultaneous Assayof a-Fetoproteinand Free p Subunitof HumanChorionic Gonadotropin by Dual-LabelTime-ResolvedImmunofluorometric Assay

Juanita, S. Larsen, K. Pettersson, 1993 .

Improved cancer specificity in PSA assay using Aleuria aurantia lectin coated Eu-nanoparticles for detection.

K. Pettersson, C. Bangma, Y. van Kooyk, 2017, Clinical biochemistry.

Suboptimal response to GnRHa long protocol is associated with a common LH polymorphism.

P. Humaidan, K. Pettersson, R. Clarizia, 2009, Reproductive biomedicine online.

Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes.

K. Pettersson, M. Lepäntalo, Natalia N. Tamm, 2006, Clinical chemistry.

High-sensitivity lateral flow immunoassay with a fluorescent lanthanide nanoparticle label.

Kim Pettersson, Etvi Juntunen, Teppo Salminen, 2019, Journal of immunological methods.

VARIOUS RATIOS OF HUMAN GLANDULAR KALLIKREIN (HK2) TO FREE AND TOTAL PSA IMPROVE DISCRIMINATION BETWEEN G1-G2 AND G3 PROSTATE TUMORS

T. Piironen, K. Pettersson, M. Kwiatkowski, 1999 .

Ultrasensitive and Robust Point-of-Care Immunoassay for the Detection of Plasmodium falciparum Malaria.

K. Pettersson, D. Rohila, J. Prakash, 2020, Analytical chemistry.

Clinical Utility of Mutant Antibody-Based Assays for Determination of Internally Cleaved and Intact Forms of Free Prostate-Specific Antigen.

P. Taimen, P. Boström, K. Pettersson, 2019, The journal of applied laboratory medicine.

Prostate-specific antigen velocity for early detection of prostate cancer: result from a large, representative, population-based cohort.

P. Scardino, A. Vickers, M. Roobol, 2009, European urology.

Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy.

Kim Pettersson, L. Voipio‐Pulkki, K. Pettersson, 2005, Clinical chemistry.

Validation of Novel Biomarkers for Prostate Cancer Progression by the Combination of Bioinformatics, Clinical and Functional Studies

Matthias Nees, Pekka Taimen, Kim Pettersson, 2016, PloS one.

Studies on the effects of heparin products on pregnancy-associated plasma protein A.

P. Porela, K. Pettersson, S. Wittfooth, 2011, Clinica chimica acta; international journal of clinical chemistry.

Immunofluorometric point-of-care assays for the detection of acute coronary syndrome-related noncomplexed pregnancy-associated plasma protein A.

Kim Pettersson, Ilkka Tierala, Harri Takalo, 2006, Clinical chemistry.

Use of high-capacity surface with oriented recombinant antibody fragments in a 5-min immunoassay for thyroid-stimulating hormone.

K. Pettersson, M. Vehniäinen, E. Brockmann, 2010, Analytical biochemistry.

Monoclonal Antibody-Based Discrepancies betweenTwo-SiteImmunometric Tests forLutropin

K. Pettersson, Y. Ding, 1991 .

Serum osteocalcin in relation to calcaneal bone mineral density in elderly men and women: a 5-year follow-up

E. Heikkinen, H. Suominen, K. Väänänen, 2002, Journal of Bone and Mineral Metabolism.

A highly sensitive and specific time resolved fluorometric bridge assay for antibodies to HIV-1 and -2.

T. Soukka, K. Pettersson, S. Swaminathan, 2011, Journal of virological methods.

All-in-one dry-reagent time-resolved immunofluorometric assay for the rapid detection of HIV-1 and -2 infections.

K. Pettersson, N. Khanna, Etvi Juntunen, 2015, Journal of virological methods.

Expression of prostate specific antigen on the surface of a filamentous phage.

H. Lilja, M. Karp, K. Pettersson, 1994, Biochemical and biophysical research communications.

Arraying prostate specific antigen PSA and Fab anti‐PSA using light‐assisted molecular immobilization technology

M. T. Neves-Petersen, S. Petersen, K. Pettersson, 2010, Protein science : a publication of the Protein Society.

Rapid and sensitive cardiac troponin I immunoassay based on fluorescent europium(III)-chelate-dyed nanoparticles.

Kim Pettersson, K. Pettersson, Timo Lövgren, 2012, Clinica chimica acta; international journal of clinical chemistry.

Reactivity of Anti-PSA Monoclonal Antibodies with Recombinant Human Kallikrein-2

H. Lilja, T. Piironen, K. Pettersson, 1999, Tumor Biology.

A Four-Kallikrein Panel Predicts Prostate Cancer in Men with Recent Screening: Data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam

P. Scardino, A. Vickers, M. Roobol, 2010, Clinical Cancer Research.

Anti-HCV immunoassays based on a multiepitope antigen and fluorescent lanthanide chelate reporters.

K. Pettersson, N. Khanna, Etvi Juntunen, 2016, Journal of virological methods.

All-in-one dry-reagent time-resolved immunofluorometric assay for the rapid detection of HIV-1 and -2 infections.

K. Pettersson, N. Khanna, Etvi Juntunen, 2015, Journal of virological methods.

H. Lilja, A. Christensson, T. Piironen, 1995, Clinical chemistry.

Cardiac troponin I in congenital heart defects with pressure or volume overload

K. Pettersson, E. Jokinen, J. Pihkala, 2013, Scandinavian cardiovascular journal : SCJ.